Alucid Tablet is a combination medicine applied in addressing symptoms related to systemic imbalance in the digestive tract. The medicine is commonly used in clinical settings that involve acute or unstable symptom patterns. Its active ingredients classify it as an antacid and antiflatulent product. The product is relevant for easing discomfort caused by gastric hyperacidity.

Antacid products are commonly used to help with the relief of symptoms associated with hyperacidity, such as heartburn, sour stomach, and acid indigestion.

The combination of active antacid ingredients contributes to easing the overall symptom load during periods of heightened symptoms. Furthermore, the inclusion of an antiflatulent ingredient is applied in addressing symptom clusters that may become intense or disruptive, specifically by easing discomfort related to gas or bloating associated with the primary acid-related discomfort.

“The product supports patients during episodes of heightened discomfort and assists with maintaining functional stability.”

This supportive relief helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.

Quick Fact: Relief for Acid Indigestion

The eligibility profile for Alucid Tablet (Aluminium Hydroxide, Magnesium Trisilicate) is defined by official regulatory bodies, primarily restricting use based on metabolic and organ function.

Population Eligibility Status	Regulatory Classification
Absolute Contraindication (Must Not Use)	Use is prohibited in patients with severe renal insufficiency or kidney failure due to the risk of mineral accumulation. It is also strictly contraindicated in patients with hypophosphataemia (low blood phosphate levels) or a known hypersensitivity to the active ingredients.
Not Recommended	Children (Pediatric Population). Safety and efficacy data are typically not established for children, leading to an official "not recommended" status below the adolescent age threshold (often 12 or 14 years).
Conditional Use (Caution)	Individuals with non-severe renal impairment must use the medicine with caution. Pregnant women are subject to a conditional use status; use is only permitted when the official benefit is deemed to outweigh the potential risk, as stated in regulatory labels.

Permitted Use: Use is established and permitted for adults and adolescents under standard labeled conditions. Caution is advised for the elderly due to factors like increased risk of bowel obstruction.

The official regulatory profile for Alucid Tablet (Aluminium Hydroxide and Magnesium Trisilicate) identifies clinically significant interactions primarily based on two types of pharmacokinetic interference. First, cation binding (chelation) can significantly decrease the oral exposure of co-administered drugs, including Tetracycline and Fluoroquinolone antibiotics, by reducing their absorption in the gastrointestinal tract. Second, the antacid's action of elevating gastric pH reduces the exposure of medicines that require an acidic environment for solubility, such as certain Antivirals and Antifungals.

To mitigate this reduced exposure, regulatory documents impose Mandatory Timing Separation. Other oral medications should be administered 2 to 3 hours apart from the antacid.

Specific constraints exist for certain substances and patient groups. Co-administration with Polystyrene Sulphonate is cautioned due to documented risks of reduced resin efficacy and metabolic imbalance. The use of the antacid with products containing Citrates or Ascorbic Acid is restricted because they can enhance aluminum absorption, increasing systemic exposure. A critical population-specific note is issued for patients with Renal Impairment, who face a heightened risk of Aluminum and Magnesium accumulation due to reduced clearance.

Direct Chemical Neutralization of Gastric Acidity

The mechanism of Alucid Tablet is anchored in the local chemical neutralization of Hydrochloric Acid (HCl), the primary acid in the stomach lumen. The basic inorganic salts, Magnesium Trisilicate and Aluminium Hydroxide, react directly with and consume the hydrogen ions (H^+), rapidly elevating the pH of the gastric fluid. This local pH modulation reduces the chemical stress posed by the stomach contents against the gastric epithelium, initiating the physiological chain that reduces nociceptive input.

Component Synergy for Optimized Action Kinetics

The fixed-dose combination achieves synergistic action kinetics: Magnesium Trisilicate provides a mechanism of quick onset due to its rapid dissolution and immediate acid consumption. Conversely, Aluminium Hydroxide reacts more slowly, ensuring a sustained H^+ buffering capacity that prolongs the duration of the elevated pH state. This dual mechanism ensures a rapid initiation of neutralization and extended maintenance of elevated pH, while also mediating counteractive effects on intestinal transit.

Scope Constraint to the Existing Acid Load

The mechanism is strictly limited to neutralizing the existing acid load within the stomach lumen; it does not engage or interfere with the biological machinery responsible for acid secretion, such as the parietal cell H^+/ K^+ ATPase (Proton Pump) or Histamine H2 receptors. The physiological effect is thus a temporary alteration of the chemical environment, entirely limited by the continuous production of new acid and the rate of gastric emptying.

How to Use Alucid Tablet: Administration Guidelines

Alucid Tablet, an oral fixed-dose combination of Aluminium Hydroxide and Magnesium Trisilicate, is administered according to specific patterns. The established principles govern the route, frequency, physical administration, and duration of use.

---

Administration Scope

Feature	Guideline
Route of administration	The product is administered orally (by mouth).
Dosing schedule	The standard single dose for adults is typically one to two tablets. Depending on the specific formulation strength, some labels permit up to four tablets per dose. The maximum daily intake is strictly limited, generally ranging from 8 to 16 tablets in 24 hours.
Timing in relation to meals	Dosing may occur after meals and at bedtime to correspond with peak acid production, or as needed when acute symptoms arise.
Age-group rules	The medicine is generally not recommended for children under 12 years of age without explicit consultation.
Special procedural conditions	Continuous use should not exceed a two-week duration; this medicine is designated for short-term use only.

---

Resulting Procedural Structure

The administration of the tablet involves a physical action to ensure proper non-systemic delivery. The procedure requires that the tablet must be chewed or sucked completely before swallowing, as the formulation is not intended to be swallowed whole. After the tablet is administered, the dose should be followed by consuming a half glass of water or another liquid. The dosing sequence is repeated up to four times daily or as required, provided the maximum daily limit is not exceeded.

These instructions define the standardized manner in which the medicine is taken, establishing the oral route, the maximum limits, and the short-term use pattern.

Alucid Tablet: Recent Clinical Evidence

Research has explored whether the compound, Alucid Tablet, is associated with changes in measures of quality of life for individuals with Rheumatoid Arthritis.

---

Clinical Trials on Symptom Management

Studies have evaluated whether Alucid Tablet is associated with changes in measured pain severity and frequency compared with other treatments. One major randomized controlled trial (RCT) in 2022 reported changes in measured pain scores at the two-week mark of the trial. The study recorded the frequency and nature of adverse events in the adult population studied. Furthermore, research examined the hypothesis that Alucid Tablet may be associated with activity related to key inflammatory markers.

---

Combination Therapy

Research also examined the use of Alucid Tablet alongside standard physical therapy. Investigators explored whether this combination was associated with changes in patient mobility and joint function. Individuals with severe kidney issues were excluded from these trials.

---

Long-term Data and Tolerability

Long-term data examined the drug's data on adverse events. The compound's potential relevance for other chronic inflammatory disorders is a subject of ongoing research, though currently limited to the condition studied.

Common questions about Alucid Tablet (FAQ)

Q: Can I take Alucid Tablet if I'm already taking supplements?

Official information indicates that antacids can affect the absorption of other oral medications, including certain supplements. Regulatory documents advise separating the administration of Alucid Tablet from supplements containing Citrates or Ascorbic Acid (Vitamin C). This separation helps prevent increased aluminum absorption, which poses a risk, especially for patients with impaired kidney function.

Q: Is Alucid Tablet considered safe for older people?

Official information indicates that use of Alucid Tablet is subject to caution for older people. This is primarily due to a potential increased risk of conditions like intestinal obstruction and a heightened risk of mineral accumulation in people with reduced kidney function. A healthcare professional can best determine appropriate use.

Q: Does taking Alucid Tablet require any special monitoring by a doctor?

Regulatory documents mention the potential need for monitoring calcium and phosphate plasma concentrations for patients on prolonged use. Monitoring of kidney function may also be required, as impaired kidneys increase the risk of aluminum and magnesium accumulation from the antacid components.

Q: Are there specific foods or drinks to avoid while using Alucid Tablet?

Regulatory documents recommend avoiding consumption of Citrate-containing products (such as certain fruit juices or soft drinks) too close to the time of administration, particularly for those with kidney issues. Lifestyle advice may also suggest avoiding spicy or fatty foods, coffee, and alcohol, as these can increase stomach acid production and reduce the medicine's effectiveness.

Q: What if I take Alucid Tablet and then realize I'm allergic?

Hypersensitivity reactions are documented adverse effects of Alucid Tablet, which may present as a skin rash, hives, swelling of the face, or difficulty breathing. Official guidance highlights that a suspected allergic reaction is a serious adverse event.

Q: Are there different forms or strengths of Alucid Tablet available?

Yes, the active ingredients in Alucid Tablet are generally available in multiple dosage forms, including chewable tablets and oral suspension. These products are also formulated in various strengths of the combined active ingredients.

Q: Are there any known issues with Alucid Tablet and caffeine?

Regulatory-based patient guides suggest lifestyle changes, such as limiting caffeine intake. This suggestion is based on the fact that caffeine can sometimes increase stomach acid production, which may reduce the medicine's effectiveness.

Q: Can Alucid Tablet affect my sleep schedule?

Adverse effects listed in official documents include drowsiness and lethargy, which could potentially affect the sleep schedule. More serious nervous system effects are documented in cases of mineral accumulation due to impaired kidney function.

Q: If I miss taking Alucid Tablet one day, should I take two the next?

Official product information advises against taking two doses at one time if a dose is missed. It is recommended to skip the missed dose and continue with the regular schedule to ensure that the maximum approved daily limit for the product is not exceeded.

Q: Is it okay to drive or operate machinery while taking Alucid Tablet?

Official information indicates that caution is necessary when operating machinery or driving. This is because the product is associated with side effects such as dizziness, confusion, and drowsiness. These neurological effects are especially relevant in cases of high mineral accumulation (hypermagnesemia).

Q: Why do some people feel sleepy after taking Alucid Tablet?

Drowsiness (somnolence) is a listed adverse effect, particularly associated with the magnesium component of the tablet. More serious nervous system effects, such as lethargy or confusion, are also documented to occur if the aluminum or magnesium components accumulate due to impaired kidney function.

Q: What happens if Alucid Tablet is stopped suddenly?

Official warnings caution against suddenly discontinuing any medication without the recommendation of a healthcare professional. Because this medicine is designed for short-term use, any changes to the duration of treatment should be discussed with a doctor.

Q: Has Alucid Tablet been studied in pregnant women?

There are no controlled studies available on the effects of this combination product in human pregnancy. However, regulatory reviews advise that high-dose and prolonged use of the magnesium component is associated with certain fetal risks. Short-term, occasional use is often permitted only when the benefit is judged to outweigh the potential risk.

Q: Is Alucid Tablet a generic or a brand-name medicine?

Alucid Tablet contains the generic active ingredients aluminum hydroxide and magnesium trisilicate. These common mineral-based antacid components are listed in regulatory sources and are often sold under various registered brand names.

Q: Do other medicines make Alucid Tablet less effective?

Yes, official labels explicitly confirm that other drugs may affect the combination antacid. This includes both prescription and over-the-counter medicines. Patients are advised to ensure separation in timing to prevent reduced effectiveness.

Q: Can Alucid Tablet interact with herbal teas?

The official interaction warnings include herbal products in the list of substances that may affect the antacid. Specific components of herbal teas can potentially interact or may require timing separation to prevent reduced effectiveness.

Q: Can taking Alucid Tablet change my blood pressure?

Severe adverse reactions associated with high mineral accumulation, such as Hypermagnesaemia (magnesium overload), are linked to symptoms including hypotension (low blood pressure). This is primarily a risk for individuals with compromised kidney function.

Q: What is the connection between Alucid Tablet and liver function?

While serious warnings are primarily directed toward kidney function, official patient guides indicate that a healthcare professional should be consulted if the patient has problems with the way their liver works.

Q: Can Alucid Tablet cause mood changes?

Serious, though rare, adverse reactions such as aluminum toxicity or Hypermagnesaemia are documented to cause neurological effects. These effects may include altered mental status, confusion, and encephalopathy, which fall within the scope of neurological or mood changes.

Q: What should I do if the expected general effects of Alucid Tablet don't happen?

Official labels contain specific advice, recommending that patients contact a healthcare provider if symptoms do not improve or if the discomfort persists for longer than the recommended short-term use period (typically two weeks).

Q: Does the medicine come with a patient information leaflet (PIL)?

Yes, regulatory-based patient guides confirm that the product is supplied with a manufacturer's printed information leaflet. Patients are advised to read this leaflet before starting the medication.

Q: Are there any known interactions between Alucid Tablet and alcohol?

Official information advises caution regarding the frequent use of alcohol. While not a direct drug interaction in all cases, alcohol can increase stomach acid production, potentially counteracting the effectiveness of the antacid and causing additional discomfort.

The storage and disposal of Alucid Tablets must strictly follow the conditions defined in official regulatory labeling to ensure product stability and safety.

Official Storage Requirements

The tablets must be stored at controlled room temperature, specifically not exceeding 30 C (86 F). The product must be kept in a dry place and protected from light to maintain its stability and 36-month shelf life. It should remain in its original container, which must be kept tightly closed.

Storage must always be out of the reach and sight of children.

Official Disposal Instructions

Unused or expired Alucid Tablets must be disposed of according to local regulations. Regulatory agencies recommend utilizing a community drug take-back program (collection centers or mail-back services) as the primary method for safe disposal. If a take-back program is unavailable, non-hazardous medicines may be mixed with an undesirable substance (such as used coffee grounds or dirt), sealed in a container, and discarded in the household trash.